Oppenheimer Initiates Coverage of JBT Marel (JBTM) with Outperform Recommendation
Fintel reports that on May 21, 2026, Oppenheimer initiated coverage of JBT Marel (NYSE:JBTM) with a Outperform recommendation.
Analyst Price Forecast Suggests 42.38% Upside
As of May 14, 2026, the average one-year price target for JBT Marel is $183.26/share. The forecasts range from a low of $119.18 to a high of $220.50. The average price target represents an increase of 42.38% from its latest reported closing price of $128.71 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for JBT Marel is 4,017MM, an increase of 3.53%. The projected annual non-GAAP EPS is 6.41.
What is the Fund Sentiment?
There are 415 funds or institutions reporting positions in JBT Marel. This is an decrease of 239 owner(s) or 36.54% in the last quarter. Average portfolio weight of all funds dedicated to JBTM is 0.31%, an increase of 26.15%. Total shares owned by institutions decreased in the last three months by 10.09% to 54,849K shares. 
The put/call ratio of JBTM is 0.67, indicating a bullish outlook.
What are Other Shareholders Doing?
Vanguard Portfolio Management holds 2,814K shares representing 5.41% ownership of the company.
Price T Rowe Associates holds 2,751K shares representing 5.28% ownership of the company. In its prior filing, the firm reported owning 1,459K shares , representing an increase of 46.97%. The firm increased its portfolio allocation in JBTM by 55.03% over the last quarter.
Vanguard Capital Management holds 2,330K shares representing 4.47% ownership of the company.
T. Rowe Price Investment Management holds 2,077K shares representing 3.99% ownership of the company. In its prior filing, the firm reported owning 1,317K shares , representing an increase of 36.56%. The firm increased its portfolio allocation in JBTM by 45.96% over the last quarter.
Ubs Asset Management Americas holds 1,675K shares representing 3.22% ownership of the company. In its prior filing, the firm reported owning 1,863K shares , representing a decrease of 11.22%. The firm decreased its portfolio allocation in JBTM by 88.76% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.